These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis. Paes Leme AF; Yokoo S; Normando AGC; Ormonde JVS; Domingues RR; Cruz FF; Silva PL; Souza BSF; Dos Santos CC; Castro-Faria-Neto H; Martins CM; Lopes-Pacheco M; Rocco PRM Cytotherapy; 2024 May; 26(5):444-455. PubMed ID: 38363248 [TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVs. Mitchell MI; Ben-Dov IZ; Liu C; Ye K; Chow K; Kramer Y; Gangadharan A; Park S; Fitzgerald S; Ramnauth A; Perlin DS; Donato M; Bhoy E; Manouchehri Doulabi E; Poulos M; Kamali-Moghaddam M; Loudig O J Extracell Vesicles; 2021 Jun; 10(8):e12110. PubMed ID: 34122779 [TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome. Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M Front Immunol; 2021; 12():784028. PubMed ID: 34956213 [TBL] [Abstract][Full Text] [Related]
6. Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection. Cappellano G; Raineri D; Rolla R; Giordano M; Puricelli C; Vilardo B; Manfredi M; Cantaluppi V; Sainaghi PP; Castello L; De Vita N; Scotti L; Vaschetto R; Dianzani U; Chiocchetti A Cells; 2021 Jan; 10(1):. PubMed ID: 33430260 [TBL] [Abstract][Full Text] [Related]
7. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery. Mao K; Tan Q; Ma Y; Wang S; Zhong H; Liao Y; Huang Q; Xiao W; Xia H; Tan X; Luo P; Xu J; Long D; Jin Y Cell Death Dis; 2021 May; 12(6):541. PubMed ID: 34035220 [TBL] [Abstract][Full Text] [Related]
8. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thålin C Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):878-882. PubMed ID: 33267656 [TBL] [Abstract][Full Text] [Related]
9. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. Chen YM; Zheng Y; Yu Y; Wang Y; Huang Q; Qian F; Sun L; Song ZG; Chen Z; Feng J; An Y; Yang J; Su Z; Sun S; Dai F; Chen Q; Lu Q; Li P; Ling Y; Yang Z; Tang H; Shi L; Jin L; Holmes EC; Ding C; Zhu TY; Zhang YZ EMBO J; 2020 Dec; 39(24):e105896. PubMed ID: 33140861 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles. Burrello J; Caporali E; Gauthier LG; Pianezzi E; Balbi C; Rigamonti E; Bolis S; Lazzarini E; Biemmi V; Burrello A; Frigerio R; Martinetti G; Fusi-Schmidhauser T; Vassalli G; Ferrari E; Moccetti T; Gori A; Cretich M; Melli G; Monticone S; Barile L Vascul Pharmacol; 2022 Aug; 145():106999. PubMed ID: 35597450 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity. Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705 [TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Traby L; Kollars M; Kussmann M; Karer M; Šinkovec H; Lobmeyr E; Hermann A; Staudinger T; Schellongowski P; Rössler B; Burgmann H; Kyrle PA; Eichinger S Thromb Haemost; 2022 Jan; 122(1):113-122. PubMed ID: 34077977 [TBL] [Abstract][Full Text] [Related]
15. The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research. Das S; ; Ansel KM; Bitzer M; Breakefield XO; Charest A; Galas DJ; Gerstein MB; Gupta M; Milosavljevic A; McManus MT; Patel T; Raffai RL; Rozowsky J; Roth ME; Saugstad JA; Van Keuren-Jensen K; Weaver AM; Laurent LC Cell; 2019 Apr; 177(2):231-242. PubMed ID: 30951667 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991 [TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. Andargie TE; Tsuji N; Seifuddin F; Jang MK; Yuen PS; Kong H; Tunc I; Singh K; Charya A; Wilkins K; Nathan S; Cox A; Pirooznia M; Star RA; Agbor-Enoh S JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33651717 [TBL] [Abstract][Full Text] [Related]
19. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease. Avanoglu Guler A; Tombul N; Aysert Yıldız P; Özger HS; Hızel K; Gulbahar O; Tufan A; Erbaş G; Aygencel G; Guzel Tunçcan O; Dizbay M; Öztürk MA Scand J Clin Lab Invest; 2021 Apr; 81(2):160-165. PubMed ID: 33474994 [TBL] [Abstract][Full Text] [Related]
20. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]